Growth inhibition of prostate cancer xenografts by halofuginone (Q43956506)

28 November 2017

Growth inhibition of prostate cancer xenografts by halofuginone (English)

1 reference

28 November 2017

1 reference

1 reference

Zohar Gavish

1

1 reference

28 November 2017

Jehonathan H Pinthus

2

1 reference

28 November 2017

Vivian Barak

3

1 reference

28 November 2017

Jacob Ramon

4

1 reference

28 November 2017

Arnon Nagler

5

1 reference

28 November 2017

Zelig Eshhar

6

1 reference

28 November 2017

Mark Pines

7

1 reference

28 November 2017

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

51

1 reference

28 November 2017

2

1 reference

28 November 2017

73-83

1 reference

Prostate cancer. An overview of an increasing dilemma

28 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

21 January 2018

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Molecular genetics of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Blood vessel formation: what is its molecular basis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Angiogenesis as a target for tumor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

ECM signalling: orchestrating cell behaviour and misbehaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

The collagen receptor integrins have distinct ligand recognition and signaling functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Halofuginone: a novel antifibrotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Halofuginone to prevent and treat thioacetamide-induced liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Halofuginone: a potent inhibitor of critical steps in angiogenesis progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Xenografts of primary human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

The Y-box binding protein YB-1 suppresses collagen alpha 1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Potential role of beta 1 integrin and collagen biosynthesis in estrogen-dependent reduction of apoptosis in tamoxifen-treated breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Tumor angiogenesis--new drugs on the block

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Type I collagen induces expression of bone morphogenetic protein receptor type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Inhibition of collagen type I synthesis by skin fibroblasts of graft versus host disease and scleroderma patients: effect of halofuginone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Inhibition of collagen synthesis and changes in skin morphology in murine graft-versus-host disease and tight skin mice: effect of halofuginone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Reduction in pulmonary fibrosis in vivo by halofuginone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Topically applied halofuginone, an inhibitor of collagen type I transcription, reduces peritendinous fibrous adhesions following surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Halofuginone--an inhibitor of collagen type I synthesis--prevents postoperative formation of abdominal adhesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Halofuginone, an inhibitor of collagen type I synthesis, prevents postoperative adhesion formation in the rat uterine horn model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Topical treatment of cutaneous chronic graft versus host disease with halofuginone: a novel inhibitor of collagen type I synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Estimation of collagen content of liver specimens. Variation among animals and among hepatic lobes in cirrhotic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Diphenylhydantoin sodium promotes early and marked angiogenesis and results in increased collagen deposition and tensile strength in healing wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

Suppression of angiogenesis by the antitumor agent titanocene dichloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.10059

21 January 2018

Identifiers

DOI

10.1002/PROS.10059

1 reference

28 November 2017

1 reference